1.
|
Phase: Phase IV
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446GDE22, NCT00391690
|
|
2.
|
Phase: Phase IV
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446EAU22, NCT00434447
|
|
3.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 40 to 90
Sponsor: Pharmaceutical / Industry
Protocol IDs: AVO108943, NCT00470834
|
|
4.
|
Phase: Phase IV
Type: Diagnostic, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 2007_029, MK0906-143, NCT00547079
|
|
5.
|
Phase: Phase IV
Type: Supportive care, Treatment
Status: Approved-not yet active
Age: 35 to 90
Sponsor: Other
Protocol IDs: 047838, NCT00805701
|
|
6.
|
Phase: Phase IV
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS31, EudraCT number: 2008-008604-40, NCT00884273
|
|
7.
|
Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 001-0015-211, NCT00127387
|
|
8.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: MRC-STAMPEDE, EU-205102, MRC-PR08, ISRCTN78818544, EUDRACT-2004-000193-31, NCT00268476
|
|
9.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: G050103, NCT00295802
|
|
10.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: HEC/WST0512 66N/WST 2.21, NCT00312442
|
|
11.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 79
Sponsor: Pharmaceutical / Industry
Protocol IDs: AMT/P2CA/001, LC003AURON2005, NCT00332280
|
|
12.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 45 to 80
Sponsor: Other
Protocol IDs: CURC/CUOG-AVIAS-0601, NCT00553878
|
|
13.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Prostate4809, P01 CA098012, NCT00583492
|
|
14.
|
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 40 to 75
Sponsor: NCI
Protocol IDs: UIC-2006-0706, 2006-0706, NCT00765479
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Adult
Sponsor: NCI
Protocol IDs: SWOG-9346, SWOG-9346, CAN-NCIC-PR8, CALGB-9594, ECOG-S9346, EORTC-30985, CAN-NCIC-JPR8, INT-0162, NCT00002651, PR8
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Any age
Sponsor: NCI
Protocol IDs: MDA-ID-00156, NCI-3410, 3410, NCT00024167
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Under 80
Sponsor: Other
Protocol IDs: FRE-FNCLCC-GETUG-12/0203, EU-20238, NCT00055731
|
|
18.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-0232, CTSU, NCT00063882
|
|
19.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: CALGB-90202, ECOG-CALGB-90202, NCT00079001, SWOG-CALGB-90202, CAN-NCIC-PRC2
|
|
20.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: Not specified
Sponsor: NCI
Protocol IDs: FCCC-03028, NCT00084552
|
|
21.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: PMCC-VCOG-PR-0103, PMCC-TROG-0306, NCT00110162
|
|
22.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Under 75
Sponsor: Other
Protocol IDs: FRE-FNCLCC-GETUG-14/0207, EU-20503, NCT00104741
|
|
23.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: FRE-FNCLCC-GETUG-15/0403, NCT00104715
|
|
24.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-S0421, S0421, NCT00134056
|
|
25.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 30 and over
Sponsor: Other
Protocol IDs: 05-043, NCT00116142
|
